BlackRock »

Sagimet Biosciences Inc-a shares owned by BlackRock

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by BlackRock

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 2.0M 5.42
2023-09-30 $2.8M 323k 8.80

More positions owned by BlackRock

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)

View all positions for BlackRock

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a